The briefing
The SARON study found that adding consolidation radiotherapy improved progression-free survival and local control in oligometastatic non–small cell lung cancer. However, it did not produce an overall survival benefit.
Original headline
SARON: Consolidation Radiotherapy Improves PFS but Not Overall Survival in Oligometastatic NSCLC